Asterand PLC operates in the Commercial physical research sector. Asterand plc is a holding company. The principal objective of the Company is to enable its pharmaceutical and biotechnology clients to identify relevant human disease targets, and to discover and develop new drug candidates using human tissues and thereby take safer and more effective drug candidates into the clinic. In addition, the Company maintains a portfolio of potential drug candidates, which have been discovered and developed by it. It operates in two segments: Tissue Based Solutions and Licensing. The Company offers three primary product and service lines, which includes XpressBANK, PhaseZERO and BioMAP. In addition to the human tissue biorepository, it offers custom isolations of specific cell lines and primary cells, custom designed Tissue Microarrays (TMAs) and biofluids, including blood, serum and plasma. Its subsidiaries include Asterand UK Limited, Pharmagene Laboratories Trustees Limited, Asterand, Inc. and BioSeek, LLC. On February 18, 2010, it acquired BioSeek, Inc. In our complete report available for purchase the company is compared to: Puricore PLC, Brainjuicer Group Plc and Savile Group Plc.